The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Accuray; Chugai Pharma; Daido Life; Stella pharma
Research Funding - Chugai Pharma; Ono Pharmaceutical
Travel, Accommodations, Expenses - Stella pharma
Accelerator-based BNCT in rescue treatment of patients with recurrent GBM: A multicenter phase II study.
 
Shin-Ichi Miyatake
No Relationships to Disclose
 
Shinji Kawabata
Research Funding - Stella pharma; Sumitomo Heavy Industries
 
Hiromi Goto
Research Funding - Stella pharma (Inst)
 
Yoshitaka Narita
Honoraria - Abbvie; Canon USA; Chugai Pharma; Daiichi Sankyo; Eisai; Novocure; Otsuka; Takeda
Consulting or Advisory Role - Abbvie; Sumitomo Group
Research Funding - Abbvie; Bayer; Daiichi Sankyo; Daiichi Sankyo; Eisai; Novocure; Ono Yakuhin; SBI Pharmaceuticals; Sumitomo Group; Taiho Pharmaceutical
 
Minoru Suzuki
No Relationships to Disclose
 
Katsumi Hirose
Research Funding - Stella pharma; Sumitomo Heavy Industries
Travel, Accommodations, Expenses - Stella pharma; Sumitomo Heavy Industries
 
Yoshihiro Takai
No Relationships to Disclose
 
Koji Ono
Speakers' Bureau - Sumitomo Heavy Industries
 
Takanori Ohnishi
No Relationships to Disclose
 
Hiroki Tanaka
Research Funding - Stella pharma; Sumitomo Heavy Industries
Patents, Royalties, Other Intellectual Property - Sumitomo Heavy Industries
 
Takahiro Kato
No Relationships to Disclose